Compounds > dextrothyroxine
Page last updated: 2024-08-20

dextrothyroxine and aspirin

dextrothyroxine has been researched along with aspirin in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19907 (70.00)18.7374
1990's1 (10.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (20.00)2.80

Authors

AuthorsStudies
Prof Aiuto, G1
Borhani, NO1
Berge, KG; Canner, PL; Friedewald, W; Friedman, L; Prineas, RJ; Stamler, J; Wenger, NK1
Stamler, J1
Malinow, MR1
Paredero Del Bosque Martin, V1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1
Arnold, P; Deplazes, P; Flückiger, M; Ruckstuhl, H1
Cuecuecha-Rugerio, E; Flores, YN; Hernández-Galdamez, DR; Lima-Morales, R; Méndez-Hernández, P; Nava-Zamora, A; Osorno-Romero, P; Romo-Dueñas, DK; Salmerón, J; Sancho-Hernández, CR1

Trials

3 trial(s) available for dextrothyroxine and aspirin

ArticleYear
Aspirin in coronary heart disease. The Coronary Drug Project Research Group.
    Journal of chronic diseases, 1976, Volume: 29, Issue:10

    Topics: Aspirin; Clinical Trials as Topic; Dextrothyroxine; Drug Evaluation; Estrogens; Humans; Middle Aged; Myocardial Infarction; Placebos

1976
Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin.
    Journal of the American College of Cardiology, 1986, Volume: 8, Issue:6

    Topics: Adult; Aspirin; Clofibrate; Dextrothyroxine; Estrogens; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Niacin; Time Factors

1986
Pharmacological trials: primary and secondary prevention of coronary heart disease.
    Preventive medicine, 1983, Volume: 12, Issue:1

    Topics: Aspirin; Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; Colestipol; Coronary Disease; Dextrothyroxine; Dipyridamole; Estrogens; Humans; Hypercholesterolemia; Male; Middle Aged; Niacin; Sulfinpyrazone

1983

Other Studies

7 other study(ies) available for dextrothyroxine and aspirin

ArticleYear
[Problems of arteriosclerosis epidemiology. Analysis of risk factors with a view to a possible therapy].
    Minerva medica, 1976, Dec-22, Volume: 67, Issue:62

    Topics: Anti-Inflammatory Agents; Anticoagulants; Antihypertensive Agents; Arteriosclerosis; Aspirin; Blood Platelet Disorders; Cholestyramine Resin; Dextrothyroxine; Diabetes Complications; Diet, Reducing; Europe; Fibrinolytic Agents; Humans; Hyperlipidemias; Hypertension; Nicotinic Acids; North America; Obesity; Phospholipids; Platelet Aggregation; Smoking

1976
Clinical trials on the efficacy of pharmacologic intervention reducing mortality from cardiovascular diseases.
    Cardiology, 1985, Volume: 72, Issue:5-6

    Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Aspirin; Cardiovascular Diseases; Clofibrate; Coronary Disease; Dextrothyroxine; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Estrogens; Humans; Hypertension; Myocardial Infarction; Niacin; Sulfinpyrazone

1985
Dietary and pharmacologic control of atherosclerosis regression in cynomolgus macaques (Macaca fascicularis).
    Artery, 1981, Volume: 9, Issue:1

    Topics: Animals; Antihypertensive Agents; Aorta; Arteriosclerosis; Aspirin; Cholesterol; Cholesterol, Dietary; Cholestyramine Resin; Collagen; Coronary Vessels; Dextrothyroxine; Dipyridamole; Elastin; Lipids; Lipoproteins, LDL; Macaca fascicularis; Pyrimidines

1981
[Indications for surgical treatment and medical treatment of atherosclerosis].
    Minerva medica, 1980, Oct-20, Volume: 71, Issue:40

    Topics: Arteriosclerosis; Aspirin; Cholestyramine Resin; Clofibrate; Dextrothyroxine; Dipyridamole; Humans; Hyperlipidemias; Hypolipidemic Agents; Intracranial Arteriosclerosis; Nicotinic Acids; Sitosterols; Sulfinpyrazone

1980
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023
[Case report: dirofilariasis in a dog].
    Schweizer Archiv fur Tierheilkunde, 1994, Volume: 136, Issue:8

    Topics: Animals; Arsenamide; Aspirin; Dirofilaria immitis; Dirofilariasis; Dog Diseases; Dogs; Drug Therapy, Combination; Ivermectin; Male; Microfilariae

1994
Effectiveness of a multidrug therapy consisting of Ivermectin, Azithromycin, Montelukast, and Acetylsalicylic acid to prevent hospitalization and death among ambulatory COVID-19 cases in Tlaxcala, Mexico.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2021, Volume: 105

    Topics: Acetates; Adult; Aged; Aged, 80 and over; Antiviral Agents; Aspirin; Azithromycin; COVID-19 Drug Treatment; Cyclopropanes; Drug Therapy, Combination; Hospitalization; Humans; Ivermectin; Male; Mexico; Middle Aged; Quinolines; SARS-CoV-2; Sulfides; Treatment Outcome; Young Adult

2021